Legal Representation
Attorney
Tricia L. Schulz
USPTO Deadlines
Application History
39 eventsDate | Code | Type | Description |
---|---|---|---|
Aug 1, 2024 | EXT5 | S | SOU EXTENSION 5 FILED |
Aug 1, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED |
Aug 1, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Aug 1, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 8, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED |
Feb 8, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 8, 2024 | EXT4 | S | SOU EXTENSION 4 FILED |
Oct 6, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Oct 4, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
Oct 4, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
Oct 4, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 27, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 25, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
Apr 25, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
Apr 25, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 3, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Nov 3, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Nov 3, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Oct 15, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Oct 13, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Oct 13, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
Oct 13, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
May 3, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
Feb 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jan 31, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 28, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Jan 28, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Jan 28, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Jan 28, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jan 27, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jan 27, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jan 27, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jan 10, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 8, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Aug 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
May 31, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"